Overview
HOWL market data
Price History
HOWL price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.32 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.31 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 17.5% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.27 – $2.38 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $18.8M · P/B 1.24 · P/S 0.89.
Company News
Werewolf Therapeutics shares are trading lower after the company reported Q2 financial results. Weakness may have stemmed from cash pressure, reliance on one‑time revenue from Jazz asset sale, and uncertainty around management’s strategic review.Benzinga · Jul 31, 2026, 7:37 PM
Werewolf Therapeutics Q2 EPS $0.08 Beats $(0.29) Estimate, Sales $21.000MBenzinga · Jul 31, 2026, 11:26 AM
8-K filing — Werewolf Therapeutics, Inc. (HOWL)SEC EDGAR · Jul 31, 2026, 11:06 AM
12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga · Jul 24, 2026, 5:05 PM